Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sachin Malik & Suroor A. Khan. (2014) Design and synthesis of (5-amino-1, 2, 4-triazin-6-yl)(2-(benzo[d] isoxazol-3-yl) pyrrolidin-1-yl)methanone derivatives as sodium channel blocker and anticonvulsant agents. Journal of Enzyme Inhibition and Medicinal Chemistry 29:4, pages 505-516.
Read now
Read now
J Lloyd Holder$suffix/text()$suffix/text() & Angus A Wilfong. (2011) Zonisamide in the treatment of epilepsy. Expert Opinion on Pharmacotherapy 12:16, pages 2573-2581.
Read now
Read now
Hideto Miwa. (2007) Zonisamide for the treatment of Parkinson’s disease. Expert Review of Neurotherapeutics 7:9, pages 1077-1083.
Read now
Read now
Angus A Wilfong & L James Willmore. (2006) Zonisamide – a review of experience and use in partial seizures. Neuropsychiatric Disease and Treatment 2:3, pages 269-280.
Read now
Read now
A. E. Mutlib, S. Diamond, J. Shockcor, R. Way, G. Nemeth, L. Gan & D. D. Christ. (2000) Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor. Xenobiotica 30:11, pages 1091-1110.
Read now
Read now
H. Nakasa, S. Ohmori & M. Kitada. (1996) Formation of 2-sulphamoylacetylphenol from zonisamide under aerobic conditions in rat liver microsomes. Xenobiotica 26:5, pages 495-501.
Read now
Read now
Articles from other publishers (30)
Tom S. Chan, Alexander J. Byer-Alcorace, Bachir Latli, Pingrong Liu, Hlaing H. Maw, Klairynne G. Raymond, Young-Sun Scaringella, Aaron M. Teitelbaum, Ting Wang, Andrea Whitcher-Johnstone & Mitchell E. Taub. (2023) Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin. Pharmaceutical Research.
Crossref
Crossref
Jared W. Castle, Danielle M. Butzbach, G. Stewart Walker, Claire E. Lenehan, Frank Reith, Samuel P. Costello & K. Paul Kirkbride. (2023) Microbial degradation products of lurasidone and their significance in postmortem toxicology. Drug Testing and Analysis 15:5, pages 551-565.
Crossref
Crossref
Chie Makino, Akiko Watanabe, Manabu Kato, Hideyuki Shiozawa, Hideo Takakusa, Daisuke Nakai, Tomoyo Honda & Nobuaki Watanabe. (2022) Species differences between rats and primates (humans and monkeys) in complex cleavage pathways of DS-8500a characterized by 14C-ADME studies in humans and monkeys after administration of two radiolabeled compounds and in vitro studies. Drug Metabolism and Pharmacokinetics 45, pages 100459.
Crossref
Crossref
Milena Rmandić, Ana Stajić, Jasna Jančić, Janko Samardžić, Nebojša Jović & Anđelija Malenović. (2022) Quantification of Zonisamide in Dried Blood Spots and Dried Plasma Spots by UPLC–MS/MS: Application to Clinical Practice. Molecules 27:15, pages 4899.
Crossref
Crossref
Shengying Lou & Sunliang Cui. (2022) Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary
Mechanisms. Current Medicinal Chemistry 29:19, pages 3366-3391.
Crossref
Crossref
Xiang Huang, Shiyang Dong, Hua Liu, Pingnan Wan, Tiantian Wang, Hexiu Quan, Zengcai Wang & Zengtao Wang. (2022)
Design, Synthesis, and Evaluation of Novel Benzo[
d
]isoxazole Derivatives as Anticonvulsants by Selectively Blocking the Voltage-Gated Sodium Channel Na
V
1.1
. ACS Chemical Neuroscience 13:6, pages 834-845.
Crossref
Crossref
Rohit Pal, Karanvir Singh, Shah Alam Khan, Pooja Chawla, Bhupinder Kumar & Md Jawaid Akhtar. (2021) Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction. European Journal of Medicinal Chemistry 226, pages 113890.
Crossref
Crossref
Roberto Mandrioli, Michele Protti, Lorenzo Marincich & Laura Mercolini. (2021) Ion-Channel Antiepileptic Drugs: An Analytical Perspective on the Therapeutic Drug Monitoring (TDM) of Ezogabine, Lacosamide, and Zonisamide. Analytica 2:4, pages 171-194.
Crossref
Crossref
Chengqian Li, Li Xue, Yumei Liu, Zhengjie Yang, Song Chi & Anmu Xie. (2020) Zonisamide for the Treatment of Parkinson Disease: A Current Update. Frontiers in Neuroscience 14.
Crossref
Crossref
Deepak Dalvie & Li Di. (2019) Aldehyde oxidase and its role as a drug metabolizing enzyme. Pharmacology & Therapeutics 201, pages 137-180.
Crossref
Crossref
K. P. Rakesh, C. S. Shantharam, M. B. Sridhara, H. M. Manukumar & Hua-Li Qin. (2017) Benzisoxazole: a privileged scaffold for medicinal chemistry. MedChemComm 8:11, pages 2023-2039.
Crossref
Crossref
Ian D. Wilson & Jeremy K. Nicholson. (2017) Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research 179, pages 204-222.
Crossref
Crossref
Ian D. Wilson & Jeremy K. Nicholson. 2015. Metabonomics and Gut Microbiota in Nutrition and Disease. Metabonomics and Gut Microbiota in Nutrition and Disease
323
341
.
Katarzyna M Bloch, Graeme J Sills, Munir Pirmohamed & Ana Alfirevic. (2014) Pharmacogenetics of antiepileptic drug-induced hypersensitivity. Pharmacogenomics 15:6, pages 857-868.
Crossref
Crossref
M.L. Miller, S.A. Center, J.F. Randolph, M.L. Lepherd, M.A. Cautela & C.W. Dewey. (2011) Apparent Acute Idiosyncratic Hepatic Necrosis Associated with Zonisamide Administration in a Dog. Journal of Veterinary Internal Medicine 25:5, pages 1156-1160.
Crossref
Crossref
Shigeyuki Kitamura, Kazumi Sugihara, Mie Kuwasako & Kiyoshi Tatsumi. (1997) The Role of Mammalian Intestinal Bacteria in the Reductive Metabolism of Zonisamide. Journal of Pharmacy and Pharmacology 49:3, pages 253-256.
Crossref
Crossref
S. B. Benaka Prasad, K. Vinaya, C. S. Ananda Kumar, Sanjay Swarup & K. S. Rangappa. (2008) Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study. Investigational New Drugs 27:6, pages 534-542.
Crossref
Crossref
Sabine Heberling, Ulrich Girreser, Stephanie Wolf & Bernd Clement. (2006) Oxygen-insensitive enzymatic reduction of oximes to imines. Biochemical Pharmacology 71:3, pages 354-365.
Crossref
Crossref
Ilo E. Leppik. (2004) Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 13, pages S5-S9.
Crossref
Crossref
Monish Jain & Chul-Hoon Kwon. (2003) 1,2-Benzisoxazole Phosphorodiamidates as Novel Anticancer Prodrugs Requiring Bioreductive Activation. Journal of Medicinal Chemistry 46:25, pages 5428-5436.
Crossref
Crossref
Richard A. Tschirret-Guth & Harold B. Wood. (2003)
SUBSTITUENT EFFECT ON THE REDUCTIVE
N-
DEARYLATION OF 3-(INDOL-1-YL)-1,2-BENZISOXAZOLES BY RAT LIVER MICROSOMES
. Drug Metabolism and Disposition 31:8, pages 999-1004.
Crossref
Crossref
Deepak K. Dalvie, Amit S. Kalgutkar, S. Cyrus Khojasteh-Bakht, R. Scott Obach & John P. O'Donnell. (2002) Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings. Chemical Research in Toxicology 15:3, pages 269-299.
Crossref
Crossref
F. Peter Guengerich. (2001) Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity. Chemical Research in Toxicology 14:6, pages 611-650.
Crossref
Crossref
Shigeyuki KITAMURA, Keiko NAKATANI, Koji OHASHI, Kazumi SUGIHARA, Ryuji HOSOKAWA, Yasumasa AKAGAWA & Shigeru OHTA. (2001) Extremely High Drug-Reductase Activity Based on Aldehyde Oxidase in Monkey Liver.. Biological and Pharmaceutical Bulletin 24:7, pages 856-859.
Crossref
Crossref
David R Hawkins. (1999) Use and value of metabolism databases. Drug Discovery Today 4:10, pages 466-471.
Crossref
Crossref
Ilo E. Leppik. (1999) Zonisamide. Epilepsia 40:s5, pages s23-s29.
Crossref
Crossref
E. Tanaka. (1999) Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. Journal of Clinical Pharmacy and Therapeutics 24:2, pages 87-92.
Crossref
Crossref
I. E. Leppik. 1999. Antiepileptic Drugs. Antiepileptic Drugs
485
498
.
Gregory M. Kochak, John G. Page, Robert A. Buchanan, Richard Peters & Claire S. Padgett. (1998) Steady-State Pharmacokinetics of Zonisamide, an Antiepileptic Agent for Treatment of Refractory Complex Partial Seizures. The Journal of Clinical Pharmacology 38:2, pages 166-171.
Crossref
Crossref
V.A. Eagling, J.L. Howe, M.J. Barry & D.J. Back. (1994) The metabolism of zidovudine by human liver microsomes in vitro: Formation of 3′-amino-3′-deoxythymidine. Biochemical Pharmacology 48:2, pages 267-276.
Crossref
Crossref